McGrail K, Teng J, Bentley C, ODoherty K, Burgess M
Int J Popul Data Sci. 2024; 9(1):2372.
PMID: 39620125
PMC: 11606539.
DOI: 10.23889/ijpds.v9i1.2372.
Dhamanaskar R, Abelson J
Healthc Policy. 2024; 20(SP):83-93.
PMID: 39417274
PMC: 11523114.
DOI: 10.12927/hcpol.2024.27410.
Warrier P, Ho C, Bull S, Vaz M, Vaz M
Wellcome Open Res. 2024; 6:5.
PMID: 38645686
PMC: 11026954.
DOI: 10.12688/wellcomeopenres.16558.2.
Thaldar D, Townsend B, Botes M, Shozi B, Pillay S
PLoS One. 2021; 16(8):e0256097.
PMID: 34411176
PMC: 8376038.
DOI: 10.1371/journal.pone.0256097.
Amin L, Olesen A, Mahadi Z, Ibrahim M
Asian Bioeth Rev. 2021; 13(3):297-315.
PMID: 34295385
PMC: 8245627.
DOI: 10.1007/s41649-021-00171-5.
Sharing linked data sets for research: results from a deliberative public engagement event in British Columbia, Canada.
Teng J, Bentley C, Burgess M, ODoherty K, McGrail K
Int J Popul Data Sci. 2021; 4(1):1103.
PMID: 34095532
PMC: 8142623.
DOI: 10.23889/ijpds.v4i1.1103.
Deliberations About Genomic Research and Biobanks With Citizens of the Chickasaw Nation.
Reedy J, Blanchard J, Lund J, Spicer P, Byars C, Peercy M
Front Genet. 2020; 11:466.
PMID: 32477408
PMC: 7240027.
DOI: 10.3389/fgene.2020.00466.
Hopeful and Concerned: Public Input on Building a Trustworthy Medical Information Commons.
Deverka P, Gilmore D, Richmond J, Smith Z, Mangrum R, Koenig B
J Law Med Ethics. 2019; 47(1):70-87.
PMID: 30994071
PMC: 6730638.
DOI: 10.1177/1073110519840486.
Multiple diversity concepts and their ethical-epistemic implications.
Steel D, Fazelpour S, Gillette K, Crewe B, Burgess M
Eur J Philos Sci. 2019; 8(3):761-780.
PMID: 30956737
PMC: 6414089.
DOI: 10.1007/s13194-018-0209-5.
Involving patients and the public in medical and health care research studies: An exploratory survey on participant recruiting and representativeness from the perspective of study authors.
Lander J, Langhof H, Dierks M
PLoS One. 2019; 14(1):e0204187.
PMID: 30615619
PMC: 6322864.
DOI: 10.1371/journal.pone.0204187.
Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada.
Bentley C, Costa S, Burgess M, Regier D, McTaggart-Cowan H, Peacock S
BMC Health Serv Res. 2018; 18(1):339.
PMID: 29739463
PMC: 5941483.
DOI: 10.1186/s12913-018-3117-7.
Beyond Consent: Building Trusting Relationships With Diverse Populations in Precision Medicine Research.
Kraft S, Cho M, Gillespie K, Halley M, Varsava N, Ormond K
Am J Bioeth. 2018; 18(4):3-20.
PMID: 29621457
PMC: 6173191.
DOI: 10.1080/15265161.2018.1431322.
Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey.
Polisena J, Burgess M, Mitton C, Lynd L
BMC Health Serv Res. 2017; 17(1):372.
PMID: 28549479
PMC: 5446683.
DOI: 10.1186/s12913-017-2310-4.
CJCheck Stage 1: development and testing of a checklist for reporting community juries - Delphi process and analysis of studies published in 1996-2015.
Thomas R, Sims R, Degeling C, Street J, Carter S, Rychetnik L
Health Expect. 2016; 20(4):626-637.
PMID: 27704684
PMC: 5513001.
DOI: 10.1111/hex.12493.
Deliberation to Promote Shared Sovereignty in Health Research: Four Questions to Clarify Goals, Methods, and Scope.
de Vries J, Munung S, Tindana P
Am J Bioeth. 2016; 16(10):50-2.
PMID: 27653401
PMC: 5141257.
DOI: 10.1080/15265161.2016.1214326.
Collective agency and the concept of 'public' in public involvement: A practice-oriented analysis.
Hainz T, Bossert S, Strech D
BMC Med Ethics. 2016; 17:1.
PMID: 26732279
PMC: 4702418.
DOI: 10.1186/s12910-015-0083-z.
Community engagement for big epidemiology: deliberative democracy as a tool.
McWhirter R, Critchley C, Nicol D, Chalmers D, Whitton T, Otlowski M
J Pers Med. 2015; 4(4):459-74.
PMID: 25563457
PMC: 4282883.
DOI: 10.3390/jpm4040459.
The ASTUTE Health study protocol: deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment.
Watt A, Hiller J, Braunack-Mayer A, Moss J, Buchan H, Wale J
Implement Sci. 2012; 7:101.
PMID: 23088222
PMC: 3520863.
DOI: 10.1186/1748-5908-7-101.
Communicating risks and benefits about ethically controversial topics: the case of induced pluripotent stem (iPS) cells.
Longstaff H, McDonald M, Bailey J
Stem Cell Rev Rep. 2012; 9(4):388-96.
PMID: 22941397
DOI: 10.1007/s12015-012-9407-2.
Ethical aspects of human biobanks: a systematic review.
Budimir D, Polasek O, Marusic A, Kolcic I, Zemunik T, Boraska V
Croat Med J. 2011; 52(3):262-79.
PMID: 21674823
PMC: 3118708.
DOI: 10.3325/cmj.2011.52.262.